Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07

被引：0

作者：

Yoshihiro Kakeji

Kazuhiro Yoshida

Yasuhiro Kodera

Mitsugu Kochi

Takeshi Sano

Wataru Ichikawa

Sang-Woong Lee

Kazushige Shibahara

Toshio Shikano

Masato Kataoka

Atsushi Ishiguro

Hitoshi Ojima

Yoshinori Sakai

Nobuyuki Musha

Tsunenobu Takase

Taisei Kimura

Masahiro Takeuchi

Masashi Fujii

机构：

[1] Kobe University Graduate School of Medicine,Division of Gastrointestinal Surgery, Department of Surgery

[2] Gifu University,Department of Surgical Oncology

[3] Nagoya University,Department of Gastroenterological Surgery

[4] Nihon University Itabashi Hospital,Department of Digestive Surgery

[5] Cancer Institute Hospital,Gastroenterological Surgery

[6] Showa University Fujigaoka Hospital,Division of Medical Oncology

[7] Osaka Medical College,Department of General and Gastroenterological Surgery

[8] Toyama Red Cross Hospital,Department of Surgery

[9] Yokkaichi Municipal Hospital,Department of Surgery

[10] National Hospital Organization,Department of Surgery

[11] Nagoya Medical Center,Department of Medical Oncology

[12] Teine Keijinkai Hospital,Department of Gastrointestinal Surgery

[13] Gunma Prefectural Cancer Center,Department of Gastrointestinal Medicine

[14] Tsuchiura Kyodo General Hospital,Department of Surgery

[15] Saiseikai Niigata Hospital,Department of Surgery

[16] Kainan Hospital,Department of Surgery

[17] Seirei Mikatahara General Hospital,Department of Clinical Medicine, School of Pharmacy

[18] Kitasato University,undefined

来源：

Gastric Cancer | 2022年 / 25卷

关键词：

S-1; Docetaxel; Gastric cancer; Adjuvant chemotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：188 / 196

页数：8

共 50 条

[1] Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07
Kakeji, Yoshihiro
Yoshida, Kazuhiro
Kodera, Yasuhiro
Kochi, Mitsugu
Sano, Takeshi
Ichikawa, Wataru
Lee, Sang-Woong
Shibahara, Kazushige
Shikano, Toshio
Kataoka, Masato
Ishiguro, Atsushi
Ojima, Hitoshi
Sakai, Yoshinori
Musha, Nobuyuki
Takase, Tsunenobu
Kimura, Taisei
Takeuchi, Masahiro
Fujii, Masashi
GASTRIC CANCER, 2022, 25 (01) : 188 - 196
[2] A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial).
Kodera, Yasuhiro
Yoshida, Kazuhiro
Kochi, Mitsugu
Ichikawa, Wataru
Kakeji, Yoshihiro
Sano, Takeshi
Nagao, Narutoshi
Takahashi, Masazumi
Takagane, Akinori
Nakamura, Masanori
Kaji, Masahide
Okitsu, Hiroshi
Nomura, Takashi
Matsui, Takanori
Yoshikawa, Takaki
Matsuyama, Jin
Yamada, Makoto
Ito, Yuichi
Takeuchi, Masahiro
Fujii, Masashi
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[3] Confirmed three-year RFS and OS of the randomized trial of adjuvant S-1 versus S-1 plus docetaxel after curative resection of pStage III gastric cancer (JACCRO GC-07).
Yoshida, Kazuhiro
Kodera, Yasuhiro
Kochi, Mitsugu
Sano, Takeshi
Kakeji, Yoshihiro
Ichikawa, Wataru
Kurahashi, Shintaro
Yamaguchi, Hironori
Toyokawa, Takahiro
Nakamura, Masato
Fujitani, Kazumasa
Mochizuki, Yoshinari
Ota, Mitsuhiko
Hihara, Jun
Makari, Yoichi
Takeno, Atsushi
Takeuchi, Masahiro
Fujii, Masashi
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[4] Pre-planned feasibility and safety analyses of docetaxel/S-1 combination in a phase III study comparing docetaxel/S-1 with S-1 alone as postoperative adjuvant chemotherapy for stage III gastric cancer (JACCRO GC-07).
Kakeji, Yoshihiro
Kodera, Yasuhiro
Yoshida, Kazuhiro
Kochi, Mitsugu
Takahashi, Masazumi
Kii, Takayuki
Ishiguro, Atsushi
Ishigure, Kiyoshi
Takagane, Akinori
Matsui, Takanori
Kaji, Masahide
Ichikawa, Wataru
Sano, Takeshi
Takeuchi, Masahiro
Fujii, Masashi
Nakajima, Toshifusa
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] Post-recurrent survival of a phase III trial comparing adjuvant chemotherapy with docetaxel plus S-1 versus S-1 alone in stage III gastric cancer: A post-hoc analysis of the START-2 trial (JACCRO GC-07).
Ishida, Hiroo
Sunakawa, Yu
Kodera, Yasuhiro
Yoshida, Kazuhiro
Kochi, Mitsugu
Kakeji, Yoshihiro
Sano, Takeshi
Takeuchi, Masahiro
Ichikawa, Wataru
Fujii, Masashi
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 371 - 371
[6] Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
Yamamoto, Masaaki
Omori, Takeshi
Shinno, Naoki
Hara, Hisashi
Mukai, Yosuke
Sugase, Takahito
Takeoka, Tomohira
Mikamori, Manabu
Kanemura, Takashi
Hasegawa, Shinichiro
Akita, Hirofumi
Haraguchi, Naotsugu
Nishimura, Junichi
Wada, Hiroshi
Matsuda, Chu
Yasui, Masayoshi
Miyata, Hiroshi
Ohue, Masayuki
ANTICANCER RESEARCH, 2023, 43 (11) : 5015 - 5024
[7] Five-year overall survival with S-1 plus docetaxel as adjuvant treatment in curatively resected pStage III gastric cancer in JACCRO GC-07
Ichikawa, Wataru
Yoshida, Kazuhiro
Kodera, Yasuhiro
Kitazawa, Masato
Hirao, Motohiro
Seto, Yasuyuki
Hibi, Kenji
Kinami, Shinichi
Watanabe, Masaya
Makino, Shigeto
Kochi, Mitsugu
Sano, Takeshi
Kakeji, Yoshihiro
Takeuchi, Masahiro
Fujii, Masashi
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[8] Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Sasako, Mitsuru
Sakuramoto, Shinichi
Katai, Hitoshi
Kinoshita, Taira
Furukawa, Hiroshi
Yamaguchi, Toshiharu
Nashimoto, Atsushi
Fujii, Masashi
Nakajima, Toshifusa
Ohashi, Yasuo
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4387 - 4393
[9] Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study)
Masashi Fujii
International Journal of Clinical Oncology, 2008, 13
[10] Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study)
Fujii, Masashi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (03) : 201 - 205

← 1 2 3 4 5 →